Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shreeram Aradhye currently holds 7,806 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shreeram Aradhye has been a net seller of DRNA stock. They have purchased $0 and sold $44.1K worth of shares.
Shreeram Aradhye's most recent insider trade was on Dec 28, 2021, when they sold 6,973 shares at $38.25 per share.
Shreeram Aradhye serves as Executive at Dicerna Pharmaceuticals Inc (DRNA). They have executed 5 insider transactions totaling $44.1K over their tenure at the company.
Shreeram Aradhye holds the position of Executive at Dicerna Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Shreeram Aradhye has shown a selling trading pattern, with $0 in total purchases and $44.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shreeram Aradhye was on Dec 28, 2021, when they sold $266.7K worth of DRNA shares. This transaction involved 6,973 shares at $38.25 per share.
Shreeram Aradhye currently owns 7,806 shares of Dicerna Pharmaceuticals Inc (DRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shreeram Aradhye's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shreeram Aradhye has 5 Form 4 filings on record as an insider at Dicerna Pharmaceuticals Inc.
Set alerts for Shreeram Aradhye and 40,000+ other insiders.